Reuters logo
BRIEF-Innate Pharma: Cash and cash equivalents at Dec. 31, 2016 of 230.7 million euros
March 7, 2017 / 6:19 AM / 9 months ago

BRIEF-Innate Pharma: Cash and cash equivalents at Dec. 31, 2016 of 230.7 million euros

March 7 (Reuters) - Innate Pharma SA:

* Cash and cash equivalents at Dec. 31, 2016 230.7 million euros ($244.27 million) versus 152.9 million euros year ago

* FY net profit of 12.6 million euros versus loss of 6.7 million euros year ago

* FY operating profit of 7.6 million euros versus loss of 10.8 million euros year ago

* FY revenue 65.7 million euros versus 25.1 million euros year ago Source text for Eikon: Further company coverage: ($1 = 0.9445 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below